cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top

Editorial Board

Editor-in-Chief

Editorial Board Members

  • Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
    Research Interests: non-coding RNAs expression, signaling in cancer metastasis, circulating and tissue biomarkers.
  • Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
    Research Interests: ATP-binding cassette (ABC) drug transporters, drug resistance, membrane biochemistry, chemoresistance, transport proteins.
  • Fred Wyszkowski Cancer Research Laboratory, Technion - Israel Institute of Technology, Haifa, Israel.
    Research Interests: molecular mechanisms of anticancer drug resistance.
  • Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
    Research Interests: apoptosis, immunotherapy resistance, cancer drug resistance.
  • Oncology Department,Medway NHS Foundation Trust, Kent, UK.
    Research Interests: cancer treatment, cancer in pregnancy, cancer diagnostics, cancer biology, cancer biomarkers, gynaecological cancers, urological cancers, colorectal cancer, autoimmunity.
  • Institute of Experimental and Clinical Pharmacology, Christian Albrechts University Kiel, Hospitalstr. 4, Kiel, Germany.
    Research Interests: cancer biology, pharmacokinetics, genotyping, mutation, DNA, genetics, enzymes, drug safety, pharmaceutical development, intensive care medicine.
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
    Research Interests: myelodysplastic syndromes, hematological malignancies, lymphoma, multiple myeloma, hematologic diseases, clinical hematology, blood disorders, acute myeloid leukemia, chemotherapy, leukemia, acute lymphoblastic leukemia.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY, USA.
    Research Interests: ABC transporters, multidrug resistance, cancer pharmacology.
  • Department of Hematology, Amsterdam University Medical Center, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
    Research Interests: proteasome inhibitors, minimal residual disease, clonal evolution, splicing, cellular drug addiction, hematology, drug combination studies.
  • Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA.
    Research Interests: cancer therapeutics, rational combination of drugs, molecular mechanisms, drug combinations synergize, breast, brain, liver/pancreatic cancers.
  • Department of Pharmaceutical Biology, Institute of Biochemistry and Pharmacy, Johannes Gutenberg University, Staudinger Weg 5, Mainz, Germany.
    Research Interests: natural product chemistry, medicinal and pharmaceutical chemistry, virtual drug screening, transcriptomics, network pharmacology, biochemistry, drug development, apoptosis, cancer biology.
  • Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
    Research Interests: p53 tumor suppression, autophagy, cell death signaling pathways, DNA damage, TRAIL pathway, hypoxia, drug resistance, novel therapeutics, translational oncology.
  • Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia.
    Research Interests: pancreatic cancer, exosomes, lipid metabolism, membrane transporters, signal transduction, cancer invasion and metastasis, phosphoinositide signalling, cannabinoids.
  • Oncoclinica Group, Oncoclinical Institute, Rio de Janeiro, Brazil.
    Research Interests: immune microenvironment, non-small-cell lung cancer.
  • Department of Experimental Research (Cancer Institute), Sun Yat-sen University, Guangzhou, China.
    Research Interests: ABC transporter, cancer therapy, chemotherapy resistance, multidrug resistance, immune checkpoint blockade, leukemia.
  • Laboratory of Molecular Cancer Biology, Department of Biomedical Sciences, Faculty of Medicine, University of Namur, Namur, Belgium.
    Research Interests: ATP-binding cassette transporters, cancer multidrug resistance mechanisms, pharmacogenomics, cancer biology, transcriptomics.
  • Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza, Pisa, Italy.
    Research Interests: molecular pharmacology, chemoresistance, pancreatic cancer, thoracic cancers.
  • Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
    Research Interests: colorectal cancer, fluoropyrimidine, thymidylate synthase, DNA topoisomerase, aberrant signaling pathways in tumor cells.
  • Cancer Biology Laboratory, Lutheran University of Brazil, Canoas, Brazil.
    Research Interests: breast cancer, colon cancer, cell culture, apoptosis.
  • Department of Urologic Oncology, Case Western Reserve University, Cleveland, Ohio, USA.
    Research Interests: cancer chemoprevention, cancer therapeutics, drug resistance, drug repurposing, translational oncology, cancer biology, signal transduction, apoptosis, antioxidant activity, artificial intelligence, cancer biomarkers, diet nutrition and cancer, drug delivery, toxicology, epigenetics, inflammation, cancer stem cells.
  • Clinical Pharmacy Group, Department of Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany.
    Research Interests: capillary electrophoresis, chromatography, pharmacokinetics, drug safety, oncology.
  • Institut de Cancérologie de l'Ouest, Université de Nantes, Saint-Herblain, France.
    Research Interests: circulating tumour cells, pathogenesis of bone sarcoma, osteoclast differentiation, metastatic process.
  • Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.
    Research Interests: autophagy, cancer progression, lysosomal, DNA, pH regulation.
  • Department of Rheumatology, Amsterdam Rheumatology and immunology Center (ARC), Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
    Research Interests: rheumatology, cancer biology and immunology, imaging and biomarkers, inflammatory diseases, antifolates, proteasome inhibitors, (multi) drug resistance.
  • Division of Medical Oncology, University of Basel, Basel, Switzerland.
    Research Interests: thoracic malignancies, clinical pharmacology, pharmacogenetics, pharmacokinetics, immunotherapy.
  • Department of Molecular Medicine, City of Hope's comprehensive cancer center, Duarte, CA, USA.
    Research Interests: chemical genomics, Wnt signaling.
  • Institute of Pharmacy, University of Bonn, Bonn, Germany.
    Research Interests: fluorescence microscopy, cell culture, live cell imaging, fluorescence imaging, flow cytometry, western blot analysis, cancer biology, immunofluorescence staining, intracellular trafficking, synthesis.
  • Faculty of Health Sciences, University of Macau, Macau, China.
    Research Interests: novel therapeutic antibodies development, venom-based peptide & natural biomolecule prototype drugs development, cancer biomarkers & immunotherapy markers discovery for prognostic and therapeutic validation
  • Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
    Research Interests: signaling pathways, cross-talk between cell adhesion molecules, extracellular matrix proteins and growth factor receptors in vitro and in vivo systems, prostate cancer cells, signals directing distant localization, cellular and molecular characterization.
  • Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.
    Research Interests: bioinformatics, multi-omics, transcriptomics, proteomics, pharmacogenomics, metabolomics, microbiome analysis, machine learning, translational research, biomarker discovery, oncogenomics, multidrug resistance: MDR, P-glycoprotein, ABCG2, ATPase activity, transport kinetics.
  • Laboratory of Experimental Hepatology and Drug Targeting, National Institute for Study of Liver and Gastrointestinal Diseases, University of Salamanca, Salamanca, Spain.
    Research Interests: hepatology and drug targeting, liver and gastrointestinal diseases.
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
    Research Interests: leukemia, myelodysplastic syndromes, multiple myeloma, hematologic diseases, lymphoma, blood disorders, stem cell transplantation, chemotherapy, clinical hematology, hematology.
  • Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, The Netherlands.
    Research Interests: HLA (human leukocyte antigen), MHC, histocompatibility, immunotherapy, cancer research, clinical immunology, cancer vaccines.
  • School of Biosciences, University of Kent, Canterbury, UK.
    Research Interests: virology, emerging infectious diseases, apoptosis, virus, PCR, cancer cell line.
  • Department of Flow and Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
    Research Interests: leukemia, lymphoma, imaging flow cytometry, multidrug resistance mechanisms, immunologically-based diseases, DNA in solid tumors.
  • Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
    Research Interests: leukemia, antimetabolites and metal-based drug resistance, gastrointestinal cancers, cancer pharmacogenomics, pharmacogenetics.
  • Department of Pathology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
    Research Interests: programming tumor microenvironment by nanoparticles, anti-angiogenic property of inorganic nanoparticles, metabolic enzyme and angiogenesis, identification of new molecular targets using nanotechnology, nanoendocytosis, understanding cellular processes using engineered nanoparticles, metabolic enzymes in cancer.
  • Molecular Pharmacology, School of Pharmaceutical Sciences (EPGL), University of Geneva, Geneva, Switzerland.
    Research Interests: multi drug combinations, drug-drug interactions, acquired drug resistance, cancer organoids, cancer treatment, tumor angiogenesis, targeted therapies.
  • Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
    Research Interests: molecular biology, p53, DNA damage, apoptosis, cytotoxicity, pharmacology, cancer cell line.
  • School of Pharmacy, University of Huddersfield, Huddersfield, UK.
    Research Interests: tumour hypoxia, cancer metabolism, hypoxia activated prodrugs, drug discovery (including phenotypic drug evaluation), drug delivery to the tumour microenvironment.
  • Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
    Research Interests: sarcoma, neoplasms, neurilemmoma, gastrointestinal stromal tumors, breast neoplasms, leiomyosarcoma, neoplasm metastasis, ewing, liposarcoma, myxoid, liposarcoma.
  • Department of Oncology, University of Torino Torino, Italy.
    Research Interests: chemo-immunoresistant tumor models, lung cancer, prostate cancer, breast cancer, malignant pleural mesothelioma, glioblastoma multiforme, multiple myeloma.
  • Department of Genetics, Physical Anthropology and Animal Physiology (School of Medicine) of the University of the Basque Country (UPV/EHU), Basque Country, Spain.
    Research Interests: molecular mechanisms of malignant transformation, protein ubiquitination, nucleocytoplasmic transport.
  • Nova Medical School (NMS), Universidade Nova de Lisboa/Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
    Research Interests: genetics, bacterial cell culture, immunohistochemistry, biochemistry, genomics, PCR, gene expression, cell culture, DNA, cancer biology.
  • Apoptosis Research Centre, National University of Ireland, Galway, Ireland.
    Research Interests: apoptosis, endoplasmic reticulum, UPR signaling in cancer, IRE1, PERK, drug discovery, biomarker discovery.
  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
    Research Interests: cancer, cellular and molecular mechanisms, diagnostics and therapeutics, gastrointestinal cancer.
  • Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Australia.
    Research Interests: haematology, aggressive lymphoma, acute leukemia, myelodysplasia.
  • College of Chemistry, Chemical Engineering and Biotechnology, Donghua Univeristy, Shanghai, China.
    Research Interests: Development of organic/inorganic hybrid nanoplatforms and microfluidic platforms for sensing, imaging, and theranostic applications, in particular for precision cancer imaging and therapy.
  • Division of Pharmaceutics & Pharmaceutical Chemistry College of Pharmacy, The Ohio State University, Columbus, OH, USA.
    Research Interests: platinum-based drugs, tyrosine-kinase inhibitors, P-glycoprotein, cancer chemotherapy, sensitivity analysis, clinical pharmacokinetics.
  • Stanley S. Scott Cancer Center, and Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
    Research Interests: apoptosis, cell signaling and human diseases, molecular mechanisms, stem cells and human diseases, nutrition, diet and cancer.
  • Department of Biochemistry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
    Research Interests: breast cancer stem cells, genetic and epigenetic of cancer.
  • Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité – Universitätsmedizin und Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.
    Research Interests: key drivers of metastasis, MACC1, S100A4, cancer cell signaling, cancer metastasis, drug discovery.
  • Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
    Research Interests: cancer biology, genetics, genotyping, cell biology, microscopy, hepatocellular carcinoma, pharmacology, immunohistochemistry, DNA, mutation.
  • Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA.
    Research Interests: regulation of death receptors, TRAIL receptors, small therapeutic molecules, drug-induced apoptosis, Akt/mTOR signaling, cancer therapy, EGFR inhibitors, acquired resistance, lung cancer.
  • Department of Pharmaceutical Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.
    Research Interests: drug delivery, drug targeting, nanomedicine, liposomes, micelles, experimental cancer therapy.
  • Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
    Research Interests: leukemia, diffuse large B‐cell lymphoma.
  • Department of Medicine, Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.
    Research Interests: soft tissue and bone sarcomas, human-in-mouse sarcoma models, amino acid deprivation therapies, metabolic deficiencies in sarcoma, phase 1 clinical trials.
  • Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.
    Research Interests: DNA repair proteins, cellular response to chemotherapy, protein-protein interactions, post-translational modification by ubiquitin and SUMO, sulfotransferases.
  • Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
    Research Interests: hematologic malignancies, nucleoside analogs, tyrosine kinase inhibitors, bcl2 inhibitors, antibodies, DNA repair, and pharmacology.
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
    Research Interests: telomerase, prostatic neoplasms, melanoma, cisplatin, apoptosis, neoplasms.

Former Editorial Board Member

  • Departments of Pharmacology and Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. (Died October 11, 2021 (aged 91))
    Research Interests: cancer biology, lymphomas, antimetabolites.
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties